Effect of Heavy Metals on the Blood Protein Biochemistry of the Fish CYPRINUS CARPIO AND ITS USE AS A BIO-INDICATOR OF POLLUTION STRESS

Cyprinus carpio were exposed to two non-essential (Hg and Pb)and two essential (Cu and Ni) heavy metal salts at lethal andsub-lethal concentrations. Blood serum total protein, serum globulinand serum albumin was analysed every 2 hr for 24 hrs andagain at 48 and 72 hrs. Serum protein and globulin level showedan intial sharp increase from 2 to 20 hrs, followed by decline thatextend over a period of 72 hrs. Serum albumin showed an initialimmediate decline from 2 to 4 hrs, followed by an intermittent period of recovery and decline that extend over a period of 72hrs. Both lethal and sub-lethal concentrations of metal salts elicited asimilar pattern of response varying only in magnitude. The use offish blood serum protein, albumin and globulin measurements as general indicators of pollutant stress response isdiscussed.     

长链烷基化物与牛血清白蛋白相互作用的共振光散射研究

应用荧光分光度计进行共振光散射测定,研究了水相介质中长链烷基化物十二烷基硫酸钠（SLS）与牛血清白蛋白（BSA）的结合平衡。实验表明,在微酸性条件下,SLS与BSA形成的复合物引起共振散射增强,根据470mm的光散射增强信号建立了一定酸度下SLS与BSA结合的数学关系式,随着pH值的变化,二者相互作用的结合平衡常数（Kf）及每分子BSA所结合的SLS个数（n）均不相同。     

Commentary: The federal ‘Prenatally and Postnatally Diagnosed Conditions Awareness Act’

The recently enacted federal law, the ‘Prenatally and Postnatally Diagnosed Conditions Awareness Act’ (United States Public Law 110–374) seeks to improve opportunities for parents and pregnant women to anticipate and understand the likely life course of children born with Down syndrome and other (unspecified) conditions. The law is in part a response to the continued growth of prenatal screening and testing. For example, the American College of Obstetricians and Gynecologists' Practice Bulletin 77 recommends that ‘Screening and invasive diagnostic testing for aneuploidies be available to all women who present for prenatal care before 20 weeks of gestation regardless of maternal age.’ Emerging technologies anticipate an era in which the scope of prenatal screening and testing will be much larger than it is today. Inevitably, more women will find themselves facing the hard question of whether to continue or end a pregnancy in which a fetus has been found to have a significant abnormality. While the new federal law is not likely to have a major impact on obstetric practice, it may be a harbinger of renewed wide-scale public debate concerning the ethics of prenatal screening. Copyright © 2009 John Wiley & Sons, Ltd.